Lee Hambright
Stock Analyst at Bernstein
(3.67)
# 766
Out of 5,141 analysts
40
Total ratings
63.33%
Success rate
5.42%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Outperform | $380 → $330 | $241.89 | +36.43% | 3 | Feb 19, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $154 → $125 | $112.21 | +11.40% | 7 | Jan 23, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $740 → $750 | $504.05 | +48.79% | 4 | Jan 23, 2026 | |
| MDLN Medline | Initiates: Outperform | $49 | $49.80 | -1.61% | 1 | Jan 12, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $97 → $99 | $98.75 | +0.25% | 2 | Jan 9, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Market Perform | $18 → $25 | $24.57 | +1.75% | 2 | Jan 9, 2026 | |
| SYK Stryker | Maintains: Outperform | $450 → $465 | $380.23 | +22.29% | 4 | Jan 9, 2026 | |
| MDT Medtronic | Maintains: Outperform | $111 → $112 | $96.86 | +15.63% | 4 | Jan 9, 2026 | |
| JNJ Johnson & Johnson | Maintains: Market Perform | $193 → $208 | $242.49 | -14.22% | 6 | Jan 9, 2026 | |
| DXCM DexCom | Maintains: Outperform | $84 → $86 | $73.08 | +17.68% | 3 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $92 → $100 | $74.58 | +34.08% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $132 → $135 | $79.78 | +69.22% | 3 | Mar 16, 2022 |
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $380 → $330
Current: $241.89
Upside: +36.43%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $154 → $125
Current: $112.21
Upside: +11.40%
Intuitive Surgical
Jan 23, 2026
Maintains: Outperform
Price Target: $740 → $750
Current: $504.05
Upside: +48.79%
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $49
Current: $49.80
Upside: -1.61%
Zimmer Biomet Holdings
Jan 9, 2026
Maintains: Market Perform
Price Target: $97 → $99
Current: $98.75
Upside: +0.25%
Tandem Diabetes Care
Jan 9, 2026
Maintains: Market Perform
Price Target: $18 → $25
Current: $24.57
Upside: +1.75%
Stryker
Jan 9, 2026
Maintains: Outperform
Price Target: $450 → $465
Current: $380.23
Upside: +22.29%
Medtronic
Jan 9, 2026
Maintains: Outperform
Price Target: $111 → $112
Current: $96.86
Upside: +15.63%
Johnson & Johnson
Jan 9, 2026
Maintains: Market Perform
Price Target: $193 → $208
Current: $242.49
Upside: -14.22%
DexCom
Jan 9, 2026
Maintains: Outperform
Price Target: $84 → $86
Current: $73.08
Upside: +17.68%
Oct 24, 2024
Maintains: Outperform
Price Target: $92 → $100
Current: $74.58
Upside: +34.08%
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $79.78
Upside: +69.22%